Evidence map›Paper›PMID 42079746›Full record

ArticleFrontiers in cellular and infection microbiology2026

A conjugated polymer antimicrobial agent triggers metabolic cascade-mediated killing of carbapenem-resistant

Shuyun Wang, Song Wang, Lin Chen, Binbin Li, Chuangxin Zhang, Donghong Yin, Jinju Duan

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Shuyun WangSchool of Pharmacy, Shanxi Medical University, Taiyuan, Shanxi, China.
Song WangDepartment of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Lin ChenSchool of Pharmacy, Shanxi Medical University, Taiyuan, Shanxi, China.
Binbin LiSchool of Pharmacy, Shanxi Medical University, Taiyuan, Shanxi, China.
Chuangxin ZhangSchool of Chemistry and Chemical Engineering, Shanxi University, Taiyuan, Shanxi, China.
Donghong YinDepartment of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Jinju DuanDepartment of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Carbapenem-resistant Methods: We developed a light-tunable conjugated polymer, P3, designed to penetrate CRKP biofilms and achieve spatiotemporally controlled activation. Its efficacy was evaluated against established CRKP biofilms in both dark and visible light conditions, assessing biofilm biomass elimination and bacterial viability. Results: P3 leveraged its intrinsic optical properties and ROS production to eliminate 50% of the CRKP biofilm in darkness. Upon visible light irradiation, its efficacy was dramatically enhanced via a triggered compensatory self-destruction (CSD) mechanism. This self-amplifying reaction catastrophically disrupted bacterial membrane integrity and oxidative balance, resulting in the internal destruction of over 80% of the biofilm and bacterial death. This action combines physical matrix breakdown with ROS-mediated biomolecular damage, leading to near-complete biofilm eradication. Discussion: Our study demonstrates that P3 functions as a "metabolic time bomb," providing a targeted, antibiotic-free strategy against structured bacterial communities. These findings highlight the significant potential of this light-controlled platform for treating resistant biofilm-associated infections.

Indexed as

Anti-Bacterial AgentsCarbapenem-Resistant EnterobacteriaceaeKlebsiella pneumoniaePolymersBiofilmsCarbapenemsHumansLightMicrobial Sensitivity TestsMicrobial ViabilityReactive Oxygen SpeciesAnti-Bacterial AgentsCarbapenemsPolymersReactive Oxygen Speciesactivity-tunablecompensatoryconjugatedCRKPmetabolic hijackingpolymerself-destructionspatiotemporal control

Identifiers

PMID42079746
PMCPMC13128601

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.